The clinical study of combination of Butylphthalide and Cerebroprotein Hydrolysate in the treatment of patients with vascular dementia
Objective To study the combination of Butylphthalide and Cerebroprotein Hydrolysate in treating vascular cognitive impairment. Methods 90 patients with vascular cognitive impairment were randomly divided into 2 groups, treatment group and control group. The treatment group of 45 cases was given Butylphthalide and Cerebroprotein Hydrolysate injection, the control group of 45 cases was only given Cerebroprotein Hydrolysate injection, with 1 month as a treatment course. The Mini-Mental State Examination(MMSE) and Activities of Daily Living(ADL) scores were used for evaluation of curative effect of the 2 groups of patients. Results After one month of treatment, The treatment group of Butylphthalide and Cerebroprotein Hydrolysate was superior to the control group of Cerebroprotein Hydrolysate injection in the the MMSE and ADL scores, there was statistical significance between 2 groups(P<0.05). Conclusion It is effective in treating vascular dementia of the combination of Butylphthalide and Cerebroprotein Hydrolysate injection, It is clear to improve patients cognitive function and the quality of life of the patients.
NETL
NSTL
万方数据
维普
